Sharps Technology Allocates $400M to Solana

Sharps Technology (STSS), a Nasdaq-listed medical device company, has made a bold move into crypto. It raised $400 million through a private placement to build a digital asset treasury focused on Solana ($SOL). Following the news, its stock jumped over 40%, closing at $10.35 and hitting a daily high of $13.28.

This move places Sharps alongside other public firms like Strategy, which famously holds over 632,000 BTC worth $71 billion. It signals growing interest in crypto as a legitimate treasury strategy for institutions.

Raise Details and Potential Upside

Sharps sold common stock and warrants at $6.50 per unit for the raise for Solana. If all warrants are exercised, the total raise could hit $1 billion. Major digital asset players participated, including ParaFi, Pantera, FalconX, Bastion Trading, and Saba Capital.

Cantor Fitzgerald led the deal as placement agent. Aegis Capital served as co-placement agent.

Why Solana?

Sharps has signed a non-binding letter of intent with the Solana Foundation. It plans to buy $50 million of SOL at a 15% discount to the 30-day average price. The purchase depends on conditions related to the raise.

To lead this new strategy, Sharps appointed Alice Zhang as Chief Investment Officer. She explained the timing: “Solana is capable of handling any tradable asset, anywhere. Demand is rising fast.”

Zhang’s comments come as Galaxy Digital, Jump Crypto, and Multicoin Capital reportedly plan a $1 billion Solana treasury fund. Institutional confidence in Solana is clearly growing.

Sharps Isn’t Leaving Healthcare

Despite the pivot, Sharps isn’t walking away from its roots. It will continue its core medical device and packaging business, including its safety syringe line. The digital asset treasury strategy will operate in parallel.

Sharps is one of the first non-crypto companies to take a large SOL position. Its move could inspire others in traditional sectors to follow.